Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum metabolomic profiles associated with subclinical and clinical cardiovascular phenotypes in people with type 2 diabetes.

Cardiovascular diabetology - 27 Apr 2022

Huang Zhe, Klaric Lucija, Krasauskaite Justina, McLachlan Stela, Strachan Mark W J, Wilson James F, Price Jackie F

Abstract excerpt

BACKGROUND: Atherosclerotic cardiovascular diseases (CVD) is the leading cause of death in diabetes, but the full range of biomarkers reflecting atherosclerotic burden and CVD risk in people with diabetes is unknown. Metabolomics may help identify novel biomarkers potentially involved in development of atherosclerosis. We investigated the serum metabolomic profile of subclinical atherosclerosis, measured using...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atherosclerosis
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cardiovascular Diseases

Share to Diabetes Mellitus, Type 2

Share to Lactates

Share to Metabolomics

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 35477395
DOI: 10.1186/s12933-022-01493-w
PMCID: PMC9047374

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum metabolomic profiles associated with subclinical and clinical cardiovascular phenotypes in people with type 2 diabetes.PMID 35477395Read ↗

Advances in Metabolomics: A Comprehensive Review of Type 2 Diabetes and Cardiovascular Disease InteractionsSemantic proximity Read ↗

Metabolomics and Proteomics in Type 2 DiabetesSemantic proximity Read ↗

Characterization of systemic metabolic phenotypes associated with subclinical atherosclerosis.Semantic proximity Read ↗

Integrative metabolomics and genomics reveal molecular signatures for type 2 diabetes and its cardiovascular complications.Semantic proximity Read ↗

Blood multiomics reveal insights into population clusters with low prevalence of diabetes, dyslipidemia and hypertension.Semantic proximity Read ↗

Metabolic Biomarkers for Peripheral Artery Disease Compared with Coronary Artery Disease: Lipoprotein and metabolite profiling of 31,657 individuals from five prospective cohortsSemantic proximity Read ↗

Examination of the Complex Molecular Landscape in Obesity and Type 2 DiabetesSemantic proximity Read ↗

Identification of putative biomarkers for type 2 diabetes using metabolomics in the Korea Association REsource (KARE) cohortSemantic proximity Read ↗

Identification of metabolomics biomarkers for type 2 diabetes: triangulating evidence from longitudinal and Mendelian randomization analysesSemantic proximity Read ↗

A combined observational and Mendelian randomization investigation reveals NMR-measured analytes to be risk factors of major cardiovascular diseasesSemantic proximity Read ↗

Relationship Among Diabetes, Obesity, and Cardiovascular Disease Phenotypes: A UK Biobank Cohort Study.Semantic proximity Read ↗

Metabotype identification via fasting and postprandial metabolomics and its association with type 2 diabetes incidence.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.